Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01951287 · ClinicalTrials.gov registry record · NA
Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overwt/Obese Adults
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT01951287: Completed NA study, sponsored by Purdue University.
NCT01951287 is a NA study that has completed, run by Purdue University. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01951287, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
Blood sugar and insulin levels after a meal may be altered by the food and beverages a person consumes. Keeping a healthy blood sugar level may help prevent and manage type 2 diabetes and related diseases. This study will look at how drinking different common beverages (milk, low-fat milk, nonfat milk, orange juice, coffee, and water) with a meal changes blood sugar and insulin levels.
Primary Outcome
Subjects will come to testing once a week for six weeks. Each testing day, subject will come in fasted, and a fasting blood draw will be taken. Subjects will then be fed a standard breakfast with one of the 6 beverages (coffee sweetened with sugar, orange juice, water, whole milk, skim milk, low fat milk). Blood will be taken at 30, 60, 60, 90, 120, 150,180,210,240 minutes after the meal.
Interventions
- OTHER Acute beverage (water) consumption
- OTHER Acute beverage (Black Coffee) consumption
- OTHER Acute beverage (Orange Juice) consumption
- OTHER Acute beverage (Whole Milk) consumption
- OTHER Acute beverage (2% Milk) consumption
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-09 |
| Phase | NA |
What the finished NCT01951287 record still lists
NCT01951287 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Acute beverage (water) consumption is the first listed.
NCT01951287 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01951287 about?
NCT01951287 is a clinical study titled "Impact of Fluid Milk on Post-meal Glycemia and Insulinemia in Overwt/Obese Adults". Blood sugar and insulin levels after a meal may be altered by the food and beverages a person consumes. Keeping a healthy blood sugar level may help prevent and manage type 2 diabetes and related diseases. This study will look at how drinking different common beverages (milk, low-fat milk, nonfat mi...
What is the current status of trial NCT01951287?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2013-08. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01951287?
The interventions under investigation include: Acute beverage (water) consumption (OTHER), Acute beverage (Black Coffee) consumption (OTHER), Acute beverage (Orange Juice) consumption (OTHER), Acute beverage (Whole Milk) consumption (OTHER), Acute beverage (2% Milk) consumption (OTHER).
Who is sponsoring clinical trial NCT01951287?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01951287's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia